# Bioethics, Ltd. (BOTH)

> Financial Services · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BOTH/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -186.0K | $ -158.1K | $ 585.7K | $ -931.2K |
| 2023 | $ 0 | $ -105.0K | $ -24.1K | $ 442.7K | $ -776.3K |
| 2022 | $ 0 | $ -104.1K | $ -28.6K | $ 420.6K | $ -679.1K |
| 2021 | $ 0 | $ -127.4K | $ -32.7K | $ 395.4K | $ -585.9K |
| 2020 | $ 0 | $ -151.8K | $ -87.5K | $ 365.1K | $ -478.7K |
| 2019 | $ 0 | $ -131.5K | $ -102.3K | $ 303.5K | $ -365.7K |
| 2018 | $ 0 | $ -97.1K | $ -58.0K | $ 250.9K | $ -267.8K |
| 2017 | $ 0 | $ -86.5K | $ -95.9K | $ 167.0K | $ -184.3K |
| 2016 | $ 0 | $ -163.2K | $ -60.2K | $ 160.0K | $ -120.1K |
| 2015 | $ 0 | $ -134.2K | $ -51.9K | $ 66.7K | $ -1.4K |
| 2014 | $ 0 | $ -300.9K | $ -42.2K | $ 25.0K | $ -5.9K |
| 2013 | $ 0 | $ -32.0K | $ -20.1K | $ 80.0K | $ -95.3K |
| 2012 | $ 0 | $ -37.6K | $ -32.5K | $ 70.0K | $ -72.8K |
| 2011 | $ 0 | $ -36.4K | $ -33.0K | $ 50.0K | $ -46.7K |
| 2010 | $ 70 | $ -25.4K | $ -36.0K | $ 30.0K | $ -22.0K |
| 2009 | $ 0 | $ -33.2K | $ 0 | $ 0 | $ -5.2K |
| 2008 | $ 0 | $ -17.9K | $ -16.2K | $ 0 | $ -1.0K |
| 2007 | $ 0 | $ -16.7K | $ -14.1K | $ 0 | $ 10.8K |
| 2006 | $ 0 | $ -23.7K | $ -23.7K | $ 0 | $ 6.8K |
| 2005 | $ 0 | $ -10.3K | $ -13.0K | $ 0 | $ 12.5K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.63 |
| Liabilities / Eq | -1.02 |
| Current Ratio | 0.02 |

## Other views

- [Metrics](https://sponda.capital/en/BOTH.md)
- [Charts](https://sponda.capital/en/BOTH/charts.md)
- [Compare](https://sponda.capital/en/BOTH/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.